In December 2019, the U.S. federal government signed a contract with one COVID-19 vaccine maker, Moderna, which "Stated. 'mRNA coronavirus vaccine candidates [are] developed and jointly owned" by both Moderna and the U.S. federal government, the article explains.
A basic summary is as follows: without the December 2019 change to U.S. law defining "Biological product," the mRNA COVID-19 vaccines may have been required to be labeled as something other than a vaccine.
Stated slightly differently, the U.S. federal government's definition of "Biological product" which was used up until a few weeks before the reported outbreak of COVID-19 may have prohibited the mRNA COVID-19 products from being labeled as vaccines.
New definition of 'biological product' weeks before COVID. It should be noted that to become approved in the United States, vaccine manufacturers are required to submit a "Biologic License Application." to the U.S. federal government.
Chemicals labeled as "Vaccines" require biologic product license applications; thus, it seems that according to the previous definition of "Biological product," any chemical entity that is a chemically synthesized polypeptide could not be labeled as a vaccine.
The law previously excluded "Any chemically synthesized polypeptide" from the definition of "Biological product." That definition would seemingly exclude the COVID-19 mRNA vaccines from being labeled as a "Biological product."
Specifically, the timing of the change - before COVID in December of 2019 - along with the apparent hurried status - burying the change on page 595 of a U.S. federal funding act - again suggests the possibility that COVID-19 may be a falsified pandemic exercise which U.S. federal government public health officials and politicians were preparing for by attempting to legally protect themselves with several significant changes to laws, strategies, and plans governing and regulating public health "Emerging threats," pandemics, vaccines, or related subjects.
https://www.lifesitenews.com/news/congress-expanded-vaccine-definition-just-weeks-before-covid-19/
No comments:
Post a Comment